Beyond Innovations For Life
PharmAbcine is a clinical-stage biotech focusing on the development of novel antibody therapeutics.
Our goal is to license-out the novel antibody candidates such as olinvacimab, PMC-309, PMC-403, and PMC-402 to global biopharmas.
Our mission is to contribute to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs.
WHAT WE DO
About Us
Executive Committee / BOD / SAB / History
More
For Investors
Stock Information / IR News / Notices
Core Technology
Fully Human Antibody / Antibody Development & Engineering
For Media
Press Release / PR Video
More
Pipeline
Olinvacimab / PMC-309 / PMC-402 / PMC-403
Contact
Location / Information / Partnership
COMPANY UPDATE
SOCIAL NETWORK
LinkdeIn
Facebook
YouTube
LinkedIn I Facebook I YouTube
COPYRIGHT BY PharmAbcine Inc. ALL RIGHTS RESERVED.
